Screening Protocol - Trial NCT06135727
Access comprehensive clinical trial information for NCT06135727 through Pure Global AI's free database. This phase not specified trial is sponsored by Topcon Corporation and is currently Enrolling by invitation. The study focuses on Glaucoma. Target enrollment is 505 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Topcon Corporation
Timeline & Enrollment
N/A
Nov 07, 2023
Dec 01, 2025
Primary Outcome
RNFL and GCL thickness
Summary
The objective of this study is to collect data for the development and validation a screening
 process using aggregate data.
 
 In this study, data collection will encompass both retrospective and prospective approaches
 across multiple sites in the United States.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06135727
Device Trial